 Yes. But we're on the path and we're still optimistic. Are there new innovations that you're hearing about that maybe aren't necessarily changing the endpoints of these post-transplant drugs? But, you know, we've heard certainly, you know, there's a lot of attention on new therapies, pig organs, you know, stem cell therapy.